News
-
-
-
-
-
-
-
-
PRESS RELEASE
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
Sanofi and Regeneron's Dupixent approved as first biologic medicine for young children with uncontrolled chronic spontaneous urticaria, expanding previous approval for adults and adolescents -
-